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Abstract: Toxocara vitulorum is an important intestinal nematode that causes great economic losses in farm animals worldwide.
However, there is a paucity in the development of effective and safe anthelmintic drugs against this parasite in buffalo calves. Therefore,
this study aimed to evaluate the antitoxocariasis efficacy of moxidectin, ivermectin, and piperazine citrate in buffalo calves. To achieve
this purpose, 130 buffalo calves were randomly selected from Kafr El-Sheikh governorate, Egypt, and were examined for the presence
of Toxocara vitulorum. Thirty calves were identified to be infected. Diseased calves were allocated randomly into 3 groups (10 each).
The first group received moxidectin pour-on, the second group received ivermectin, and the third received piperazine citrate. Clinical,
hematological, and parasitological responses of treated animals were assessed at 7, 14, 28, and 56 days after treatment. The fastest clinical
recovery and complete elimination of parasite eggs from feces were exhibited in calves treated with moxidectin. Significant inhibition of
eosinophil counts was observed in all treated calves at 1 week following treatment. From the obtained data, we conclude that moxidectin
is an alternative effective and safe drug for treatment of buffalo calves infected with Toxocara vitulorum when administrated in the pouron route under field conditions.
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1. Introduction
Toxocara vitulorum, a large gastrointestinal nematode,
affects ruminants and causes clinical problems in calves
worldwide (1,2). It commonly infects buffalo calves,
especially in tropical and subtropical countries (3). T.
vitulorum can also cause clinical problems in adult cattle
(4). Young calves acquire the infection mainly through the
colostrum of their infected dams during the first days after
birth (1). The larvae penetrate the wall of the calves’ small
intestines 2–8 h later and go straight to the liver via the
portal vein, while a few enter the mesenteric lymph nodes.
Next, the infection spreads to other organs of the body,
including the lungs, muscles, brain, kidneys, and peripheral
lymph nodes (5). Generally, infection with T. vitulorum is
frequently manifested by diarrhea, poor performance, and
poor growth rate (6), but high morbidity and mortality in
buffalo calves, particularly in calves aged 15 to 50 days,
were recorded (5). In other cases, intestinal obstruction
due to heavy infestation may manifest the disease (7).
In Egypt, infestation with T. vitulorum in buffalo calves
is a common clinical problem causing economic losses (8).
* Correspondence: khodery@mans.edu.eg

Unfortunately, there is paucity in anthelmintic development
for use in treatment in this widespread disease in buffalo
calves. Therefore, this study was planned to compare the
anthelmintic effects of moxidectin pour-on, ivermectin,
and piperazine citrate in buffalo calves naturally infected
with T. vitulorum. The clinical efficacy of moxidectin and
ivermectin was evaluated in a previous study (9) in calves
naturally infected with T. vitulorum, but that study included
bovine calves and the moxidectin was administrated
subcutaneously. The route of drug administration affects its
efficacy (10); therefore, moxidectin was used in this study
in pour-on form. To the best of the authors’ knowledge, this
is the first study to apply such a comparative evaluation in
buffalo calves naturally infected with T. vitulorum.
2. Materials and methods
2.1. Animals
A total of 130 buffalo calves from smallholder farms in
Kafr El-Sheikh governorate, Egypt, were examined for the
presence of T. vitulorum. The calves’ ages ranged from 2
weeks to 2 months. The animals were showing diarrhea (n
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= 34) or constipation (n = 21), or else they were apparently
healthy (n = 75). All institutional and national guidelines
for the care and use of animals were followed according
to the Egyptian Medical Research Ethics Committee (No.
14–126).
2.2. Clinical examination
Complete case history and physical examination for
each animal were obtained according to the standard
methods (11). Body condition, fecal consistency, presence
of abdominal pain, respiratory rate, heart rate, rectal
temperature, appetite, and coat condition were scored and
the sum of all of them was recorded for each animal before
treatment and at 7, 14, 28 and 56 days after treatment (12).
2.3. Parasitological examination
Fecal samples were collected directly from the rectum
of each calf and were examined for the presence of T.
vitulorum using standard techniques (13). The fecal egg
count was examined before treatment to confirm the
presence of the infection and after treatment to evaluate
the drug’s efficacy for the elimination of the parasite and
consequently to select the potential anthelmintic candidate
for T. vitulorum infection.
2.4. Hematological examination
Blood samples were collected from each animal via jugular
vein puncture and complete blood count was performed
using an electronic cell counter (MS9; Rhône Mérieux,
France). Total blood count was performed together with
clinical and parasitological examinations.
2.5. Treatment
Of 55 buffalo calves clinically infected by T. vitulorum, 30
calves were identified as having positive fecal egg counts
and were allocated randomly into three groups (10 each).
Calves in the first group were treated with moxidectin
pour-on (Cydectin Pour-On, Fort Dodge Animal Health,
Japan) at a dose rate of 0.5 mg kg–1. Ivermectin (Merck
Sharp, USA) was administrated subcutaneously to the
calves of the second group at a dose rate of 0.2 mg kg–1.
Calves in the third group received an oral dose (300 mg
kg–1) of piperazine citrate (El-Nasr Company, Egypt). A
single dose of each drug under investigation was used in
this study. Clinical, hematological, and parasitological
responses were determined in each treated group before
treatment as well as on days 7, 14, 28, and 56 following the
treatments to evaluate the efficiency of each used regimen.
2.6. Data analysis
Analysis of data was done using a commercial statistical
software program (JMP for Windows Version 5.1, SAS
Institute, Cary, NC, USA). First the Kruskal–Wallis
nonparametric ANOVA test was used to examine the
homogeneity of groups of calves, the fecal egg counts, and
the clinical index scores on the first day of admission. Then
the main effect of intervention and time was determined
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using repeated measures MANOVA on the basis of
hematological parameters and fecal egg count data. The
Wilks lambda test was selected for assessment of withingroup differences and evidence of time × drug interaction.
In the case that a statistically significant difference
between treated groups was exhibited by the Wilks lambda
test, one-way ANOVA with post hoc Tukey–Kramer
HSD multiple comparison tests were used to identify
which group was statistically significant different from
the other groups. Differences between means at P < 0.05
were considered significant. At different time points, the
effect of treatments on clinical sum scores was evaluated
statistically by using the Kruskal–Wallis with post hoc
Dunn multiple comparison tests. At P < 0.05, the result
was considered significant.
3. Results
The severity of clinical signs varied according to the age of
calf and the degree of infestation without any alteration in
body temperature in calves. Diarrhea was observed in 20
(67%) infected calves. On the other hand, 9 (30%) calves
exhibited constipation with dark discoloration of feces
and slight tympany. Pica was shown in 19 (63%) calves.
One week after treatment by anthelmintic drugs, these
clinical signs start to disappear and the clinical sum scores
differed significantly in the moxidectin-treated group in
comparison with other treatment groups (Table 1). Two
weeks later, complete clinical recovery was observed in
calves treated with moxidectin, indicating the clinical
efficacy of moxidectin by pour-on route in treatment of
buffalo calves suffering from T. vitulorum.
On the hematological level, eosinophils were the
sole parameter that showed significant variation in T.
vitulorum-infected calves. One week after treatment, a
significant reduction of eosinophil counts was observed,
especially in moxidectin- and piperazine citrate-treated
calves. Eight weeks after treatment by moxidectin and
piperazine citrate, eosinophil counts had returned to
the normal level (Table 2). The infection had completely
disappeared from the feces of calves treated with 0.5 mg
kg–1 moxidectin pour-on 1 week after treatment (Table
3). Taken together, the clinical efficacy with significant
reductions in eosinophil counts and disappearance of
helminthic eggs in animal feces in moxidectin-treated
calves highlights the superiority of this medication in
the treatment of buffalo calves naturally infected with T.
vitulorum.
4. Discussion
In tropical countries, toxocariasis is one of the most
serious parasitic diseases causing high mortality and
morbidity in buffalo calves (14). The adult buffalo is the
source of infection while suckling calves play a potential
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Table 1. Clinical index scores (median) in buffalo calves naturally infected with T. vitulorum
and treated with moxidectin (0.5 mg kg–1), ivermectin (200 µg kg–1), or piperazine citrate (300
mg kg–1).
Days after treatment

Drug

0

7

Moxidectin (n = 10)

10

7a

Ivermectin (n = 10)

11

10

Piperazine citrate (n = 10)

11

9

b

b

14

28

56

1a

0a

0

6

b

3b

1

5

b

1

0

a

: In the same column, medians with different superscripted letters are significantly different
at P < 0.05.

a,b

Table 2. Eosinophil counts (cells/µL, mean ± SD) in buffalo calves infected with T. vitulorum and treated with moxidectin (0.5 mg kg–1),
ivermectin (0.2 mg kg–1), or piperazine citrate (300 mg kg–1).
Days after treatment

Drug

Before treatment

Moxidectin (n = 10)

2524 ± 65

1232 ± 25 a

910 ± 48 a

Ivermectin (n = 10)

2498 ± 78

1859 ± 58

b

1398 ± 49

Piperazine citrate (n = 10)

2436 ± 93

1388 ± 37 a

864 ± 27 a

7

14

28

56

750 ± 55 a
b

1214 ± 57

710 ± 64 a
1129 ± 36 b

b

612 ± 65 a

620 ± 24 a

: In the same column, means with different superscripted letters are significantly different at P < 0.05.
MANOVA fit, P < 0.01. Wilks lambda test for treatment × time interaction, P < 0.05

a,b

Table 3. Fecal egg counts in buffalo calves infected with T. vitulorum and treated with moxidectin (0.5 mg kg–1), ivermectin (0.2 mg
kg–1), or piperazine citrate (300 mg kg–1).
Days after treatment

Drug

Before treatment

Moxidectin (n = 10)

10.000 ± 1500

0.0

Ivermectin (n = 10)

11.000 ± 2000

1500 ± 110 b

1500 ± 90 a

1200 ± 110 b

600 ± 55 b

Piperazine citrate (n = 10)

11.000 ± 1600

2000 ± 90

1400 ± 70

1000 ± 105

150 ± 30 c

7

14
0.0

a

c

28
0.0

a

a

56
0.0 a

a

b

a,b,c
: In the same column, means with different superscripted letters are significantly different at P < 0.05.
MANOVA fit, P < 0.01. Wilks lambda test for treatment × time interaction, P < 0.05.

role for maintenance of the infection. The larvae do not
develop into adults in the adult animal but remain as
third-stage larvae; when infected dams become pregnant,
the larvae migrate from the liver to the mammary glands
and suckling calves receive the infection via milk (9).
Three to four weeks later, the larvae develop into adults
and then begin shedding thousands of eggs in the feces
of infected calves (15). Therefore, treatment of infected
young calves is critical in controlling toxocariasis. In

this regard, piperazine, pyrantel, febantel, oxfendazole,
levamisole (16), ivermectin (17), fenbendazole (18),
and eprinomectin (15) have exhibited efficacy against T.
vitulorum. However, side effects including diarrhea and
restlessness with parasite resistance were observed in
some animals treated with piperazine citrate and other
traditionally used antitoxocariasis agents (9). Therefore,
searching for more efficacious and safe antitoxocariasis
candidates is an urgent issue. This is the first study to
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compare the antitoxocariasis efficacy of moxidectin
pour-on with other traditional antitoxocariasis drugs in
buffalo calves. Moxidectin is a potent, broad-spectrum
endectocide known for its efficacy against a wide range of
nematodes (19). Fortunately, no side effects were reported
from the usage of moxidectin by pour-on method in
buffalo (20).
Calves under investigation were showing diarrhea,
constipation, and pica at variable rates. In contrast, a
previous study stated that diarrhea was recorded in 100%
of calves with toxocariasis (20). This discrepancy might
be attributed to the presence of a massive number of
parasites in calves’ intestinal tracts, causing constipation.
Eosinophilia detected in diseased calves was in accordance
with findings of a previous report (21).
Interestingly, the clinical index scores differed
significantly among treatment groups, suggesting rapid
response in calves treated with moxidectin pour-on.
In the present study, the inferior efficacy of ivermectin
compared with moxidectin and piperazine citrate may be
attributed to the development of resistance to such drugs
due to misuse.
On the parasitological level, the present study revealed
the supremacy of moxidectin pour-on in the treatment
of buffalo calves naturally infected with T. vitulorum. In
a similar comparison study in bovine calves, moxidectin
and ivermectin were administered subcutaneously and
exhibited equal efficacy in the treatment of T. vitulorum
(15). The differences in animal species and routes of
anthelmintic drug administration might explain such
inconsistency.
At the end of the study, although there was no
significant difference in the recovery rates in calves,

moxidectin pour-on showed rapid recovery when
compared with other treatments. Moreover, no drugs
showed any adverse effects, although ivermectin and
piperazine have been found to cause side effects in other
studies (22). In lactating buffalo, rapid and high excretion
of moxidectin in the milk should be considered (23).
Fortunately, infection with T. vitulorum is more common
in calves; consequently, no precaution need be considered
in lactating buffalo.
The limitations of the present study should be
mentioned. First, the clinical signs are not typical for all
treatment groups, as infected calves may be constipated
or diarrheic. We overcame this problem by random
allocation of treatment groups. Therefore, each group had
all forms of clinical signs. The second limitation is that the
dose of the drugs was not the same. However, the dose
instructions of the manufacturers were followed.
In summary, moxidectin can be used as a conventional
anthelmintic for the treatment of buffalo calves naturally
infected with T. vitulorum by the pour-on method
simultaneously with the application of appropriate
management procedures. Further studies are warranted
to analyze the synergistic or antagonistic effects of these
drugs when used in combination with each other and
to determine the best effective composition ratio for the
growth inhibition of T. vitulorum in clinical practice.
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